Sabby Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
2017
Q1
$669K Buy
2016
Q4
Sell
2016
Q3
$392K Sell
2016
Q2
$815K Buy
2016
Q1
$939K Buy
2015
Q2
Sell
2015
Q1
$681K Sell
2014
Q4
$1.38K Sell
2014
Q3
$2.18K Buy
2014
Q2
Hold
2014
Q1
Sell
2013
Q4
$1.26M Buy
2013
Q3
$1.36M Buy